Open AccessComment: In Response to “CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML”
Author(s) -
Smeeta Gajendra
Publication year - 2020
Publication title -
turkish journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.351
H-Index - 16
ISSN - 1300-7777
DOI - 10.4274/tjh.galenos.2020.2020.0572
Subject(s) - medicine , human leukocyte antigen , oncology , immunology , antigen